Home About us Events Media data Subscribe Links News Email alert Search Contact us Blog  
Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
  
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 		 
 
 

Epoxide Hydrolases: a Biocatalytic Technology Platform for the Production of Chiral Pharmaceutical Intermediates

Oxyrane's epoxide hydrolase technology has matured into a robust and versatile platform for the scaleable and cost-effective manufacturing of enantiopure pharmaceutical chemicals which can be seamlessly integrated into existing chemical manufacturing plants

Adriana L. Botes and Robin K. Mitra, Oxyrane UK Limited (January 2007)

    View full article    |    Back to Manufacturing section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |